LucenceINSIGHT™ predicts up to 2 sites from where the cancer signal may have originated.
The prediction is limited to these 20 cancer sites:
- Lung
- Colorectum
- Liver
- Pancreas
- Breast
- Stomach
- Nasopharynx
- Gastrointestinal Tract
- Cervix
- Endometrium
- Prostate
- Kidney
- Bladder
- Lymphoplasmacytic Lymphoma
- Eye
- Head and Neck
- Myeloid
- Non-Hodgkin Lymphoma
- Oropharynx
- Skin
An indeterminate result may occur if the signal is not from one of these cancer sites or if the gene alteration is present across multiple organs (e.g. TP53).
©2024 Lucence Diagnostics Pte Ltd. All rights reserved. All logos and trademarks are the property of Lucence or their respective owners. The information on this site is intended for audiences in Singapore and Hong Kong only.